Ibogaine is federally Schedule I in the US. However, Texas has allocated $50M for ibogaine clinical trials, signalling potential regulatory movement (Stanford News, 2024). Several US cities have decriminalised entheogens broadly. Ibogaine treatment is currently available legally in Mexico, New Zealand, and several other countries. Ayahuasca occupies a different space: the brew itself is not federally scheduled, though DMT is. US-based churches (UDV, Santo Daime) have won religious exemption cases allowing ceremonial use (ICEERS).
